Yayın:
Antiproliferative Effects of a Series of Pyrazolines on Lung Cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorKAYA TİLKİ, ELİF
dc.contributor.authorDikmen, Miriş
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0002-8159-663X
dc.contributor.orcid0000-0003-2122-5324
dc.contributor.orcid0009-0000-1090-0166
dc.contributor.orcid0000-0003-0280-5550
dc.date.accessioned2025-11-13T22:57:53Z
dc.date.issued2018-12-05
dc.identifier.doihttps://doi.org/10.3390/proceedings2251574
dc.identifier.openalexW2902246148
dc.identifier.urihttps://hdl.handle.net/11421/15892
dc.identifier.urihttps://doi.org/10.3390/proceedings2251574
dc.language.isoen
dc.rightsopenAccess
dc.subjectPyrazoline
dc.subjectLung cancer
dc.subjectCytotoxic T cell
dc.subjectMTT assay
dc.subjectAdenocarcinoma
dc.subjectIC50
dc.subjectA549 cell
dc.subjectCyclophosphamide
dc.subjectCell culture
dc.subjectCytotoxicity
dc.subjectHuman lung
dc.subjectCancer research
dc.subjectChemistry
dc.subjectPharmacology
dc.subjectCancer
dc.subjectLung
dc.subjectMedicine
dc.subjectCell
dc.subjectChemotherapy
dc.subjectIn vitro
dc.subjectOncology
dc.subjectBiology
dc.subjectInternal medicine
dc.subjectBiochemistry
dc.subjectMedicinal chemistry
dc.subject.sdg3
dc.titleAntiproliferative Effects of a Series of Pyrazolines on Lung Cancer
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5040352588
local.authorid.openalexA5019197599
local.authorid.openalexA5042645402
local.authorid.openalexA5048968214
local.authorid.openalexA5100651829

Dosyalar

Koleksiyonlar

Publications